BioSpace News Archive

New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH), today announced that it plans to release its financial results for the second quarter ended June 30, 2020, before the U.S. market open on Thursday, August 27, 2020.

Creative Medical Technology Holdings Inc., trading under the ticker symbol CELZ, announced today new data demonstrating effective suppression of stroke associated pathological molecules by AmnioStem® universal donor stem cells.

LensGen, Inc., an ophthalmic medical device company and developer of Juvene®, a disruptive fluid-optic intraocular lens for cataract and presbyopia treatment, announces the initial Closing of a $10 million of the $20 million Bridge Financing.

Technology expansion provides AbCellera with the ability to combine any two antibodies generated through its discovery platform to create full IgG bispecifics Computational protein engineering expert Dr. Tim Jacobs joins AbCellera from Dualogics VANCOUVER, British Columbia--( BUSINESS WIRE )-- AbCellera today announced the acquisition of the OrthoMab bispecific platform from Dualogics, LLC. (Dualogics). OrthoMab is a clinically validated pla

Campaign offers a chance to attend a private, virtual performance by GRAMMY®Award-winning artist and breast cancer survivor Sheryl Crow [20-August-2020] MARLBOROUGH, Mass. , Aug. 20, 2020 /PRNewswire/ -- WHAT: At the start of the COVID-19 pandemic, many health officials, professional societies and patient a

Survey also found that mental resilience can significantly reduce the impact of stress on mental health during the pandemic

Alta Schutte, Ph.D., an expert researcher in hypertension and cardiovascular disease has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership team.

Supervised consumption sites and services are an integral part of the Government of Canada’s response to the opioid overdose crisis.

Foundation Patient Council Member and veteran broadcaster Larry Gifford tapped to host monthly conversations on the latest advances in Parkinson’s disease research and care [20-August-2020] NEW YORK and VANCOUVER, BC , Aug. 20, 2020 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces the re-launch of its Parkinson’s Podcast — a mo

Romark, a research-based pharmaceutical company focused on the discovery, development and delivery of innovative new medicines, primarily in the field of infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s manufacturing facility in Manati, Puerto Rico for the production of